Shoulder Innovations, Inc.
10.70%
2,212,207
1699350
Aug 4, 2026
Aug 7, 2026, 05:08 PM
Reporting Persons (5)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Gilde Healthcare Holding B.V. | Other | 10.70% | 2,212,207 | 0 | 2,212,207 |
| Gilde Healthcare V Management B.V. | Other | 10.70% | 2,212,207 | 0 | 2,212,207 |
| Cooperatieve Gilde Healthcare V U.A. | Other | 10.70% | 2,212,207 | 0 | 2,212,207 |
| Manapouri B.V. | Other | 10.70% | 2,212,207 | 0 | 2,212,207 |
| Martemanshurk B.V. | Other | 10.70% | 2,212,207 | 0 | 2,212,207 |
Disclosure Items (2)
Common Stock, $0.001 par value per share
Shoulder Innovations, Inc.
1535 Steele Avenue SW, Grand Rapids, MI, 49507
Item 5(a) of the Schedule 13D is hereby amended and restated as follows: According to the Issuer's Quarterly Report on Form 10-K filed with the Securities and Exchange Commission on May 13, 2026, as of May 6, 2026, there were 20,738,226 shares of the Issuer's Common Stock outstanding. Gilde Healthcare is the record holder of an aggregate of 2,212,207 shares of Common Stock, which represents beneficial ownership of approximately 10.7% of the outstanding shares of Common Stock. GHCVM, as the manager of Gilde Healthcare, has the power to vote and dispose of securities held by Gilde Healthcare and may be deemed to beneficially own the securities held of record by Gilde Healthcare. GHCVM is owned by GHH. The managing partners of GHH are Manapouri B.V. and Martemanshurk B.V. As a result, each of the Reporting Persons may beneficially own an aggregate of 2,212,207 shares of Common Stock, or approximately 10.7% of the outstanding Common Stock.
Item 5(c) of the Schedule 13D is hereby amended and supplemented by adding the following: The following transactions were effected by the Reporting Persons during the past 60 days. On July 30, 2026, 28,245 shares of Common Stock were sold at a weighted average price per share of $23.36, in multiple trades ranging from $23.00 to $23.73 per share. On July 31, 2026, 20,034 shares of Common Stock were sold at a weighted average price per share of $22.73, in multiple trades ranging from $22.60 to $23.00 per share. On August 3, 2026, 10,751 shares of Common Stock were sold at a weighted average price per share of $22.71, in multiple trades ranging from $22.60 to $23.05 per share. On August 4, 2026, 99,812 shares of Common Stock were sold at a weighted average price per share of $22.77, in multiple trades ranging from $22.60 to $23.04 per share. On August 5, 2026, 7,338 shares of Common Stock were sold at a weighted average price per share of $22.64, in multiple trades ranging from $22.60 to $23.00 per share. On August 6, 2026, 2,095 shares of Common Stock were sold at a price of $22.60 per share.